The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 16, 2014

Filed:

Aug. 22, 2011
Applicants:

Baik Lin Seong, Seoul, KR;

Yo Han Jang, Goyang-si, KR;

Kwang Hee Lee, Goyang-si, KR;

Young Ho Byun, Seoul, KR;

Inventors:

Baik Lin Seong, Seoul, KR;

Yo Han Jang, Goyang-si, KR;

Kwang Hee Lee, Goyang-si, KR;

Young Ho Byun, Seoul, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); C12N 2760/16134 (2013.01); C07K 2319/50 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16162 (2013.01); C12N 7/00 (2013.01);
Abstract

Disclosed is an attenuation method of an influenza virus, that is, a reassortant virus and a preparation method thereof. The disclosed reassortant virus has, in a ratio of 6:2, genes encoding a recombinant non-toxic protein and a wild type non-toxic protein, and genes encoding toxic proteins, HA (hemagglutinin) and NA (neuraminidase), of an influenza virus, the recombinant non-toxic protein consisting of a substituted caspase recognition sequence without a change of a protein size within the wild type non-toxic protein of the influenza virus. The disclosed attenuated influenza virus shows a high attenuation without a reduction of productivity in a fertilized egg. Accordingly, the method can be used as an economically efficient live vaccine preparation method which has both safety and efficiency and can use a fertilized egg as a production system. Also, since a protein is not removed or modified during attenuation, the method can be used in combination with a conventional attenuated vaccine preparation technology such as cold-adaptation.


Find Patent Forward Citations

Loading…